Hu Zhe, Ma Jincheng, Chen Yicai, Tong Wenhua, Zhu Lei, Wang Haihong, Cronan John E
Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, College of Life Sciences, South China Agricultural University, Guangzhou, Guangdong, China; Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, College of Life Sciences, South China Agricultural University, Guangzhou, Guangdong, China.
J Biol Chem. 2021 Jan-Jun;296:100365. doi: 10.1016/j.jbc.2021.100365. Epub 2021 Feb 3.
The FabG 3-ketoacyl-acyl carrier protein (ACP) reductase of Escherichia coli has long been thought to be a classical member of the short-chain alcohol dehydrogenase/reductase (SDR) family. FabG catalyzes the essential 3-ketoacyl-ACP reduction step in the FAS II fatty acid synthesis pathway. Site-directed mutagenesis studies of several other SDR enzymes has identified three highly conserved amino acid residues, Ser, Tyr, and Lys, as the catalytic triad. Structural analyses of E. coli FabG suggested the triad S138-Y151-K155 to form a catalytically competent active site. To test this hypothesis, we constructed a series of E. coli FabG mutants and tested their 3-ketoacyl-ACP reductase activities both in vivo and in vitro. Our data show that plasmid-borne FabG mutants, including the double and triple mutants, restored growth of E. coli and Salmonella enterica fabG temperature-sensitive mutant strains under nonpermissive conditions. In vitro assays demonstrated that all of the purified FabG mutant proteins maintained fatty acid synthetic ability, although the activities of the single mutant proteins were 20% to 50% lower than that of wildtype FabG. The S138A, Y151F, and K155A residue substitutions were confirmed by tandem mass spectral sequencing of peptides that spanned all three residues. We conclude that FabG is not a classical short-chain alcohol dehydrogenase/reductase, suggesting that an alternative mode of 3-ketoacyl-ACP reduction awaits discovery.
长期以来,人们一直认为大肠杆菌的FabG 3-酮酰基-酰基载体蛋白(ACP)还原酶是短链醇脱氢酶/还原酶(SDR)家族的经典成员。FabG催化脂肪酸合成II型(FAS II)途径中关键的3-酮酰基-ACP还原步骤。对其他几种SDR酶的定点诱变研究已确定三个高度保守的氨基酸残基,即丝氨酸(Ser)、酪氨酸(Tyr)和赖氨酸(Lys),为催化三联体。大肠杆菌FabG的结构分析表明,三联体S138-Y151-K155形成了一个具有催化活性的活性位点。为了验证这一假设,我们构建了一系列大肠杆菌FabG突变体,并在体内和体外测试了它们的3-酮酰基-ACP还原酶活性。我们的数据表明,携带质粒的FabG突变体,包括双突变体和三突变体,在非允许条件下恢复了大肠杆菌和肠炎沙门氏菌fabG温度敏感突变株的生长。体外试验表明,所有纯化的FabG突变蛋白都保持了脂肪酸合成能力,尽管单突变蛋白的活性比野生型FabG低20%至50%。通过对跨越所有三个残基的肽段进行串联质谱测序,证实了S138A、Y151F和K155A残基替代。我们得出结论,FabG不是一种经典的短链醇脱氢酶/还原酶,这表明3-酮酰基-ACP还原的另一种模式有待发现。